Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada flag Canada · Delayed Price · Currency is CAD
0.0900
0.00 (0.00%)
Aug 7, 2026, 5:22 PM EST

Rapid Dose Therapeutics Revenue

Rapid Dose Therapeutics had revenue of 584.52K CAD in the quarter ending May 31, 2026, a decrease of -25.32%. This brings the company's revenue in the last twelve months to 2.58M, up 4.30% year-over-year. In the fiscal year ending February 28, 2026, Rapid Dose Therapeutics had annual revenue of 2.77M with 33.00% growth.

Revenue (ttm)
2.58M
Revenue Growth
+4.30%
P/S Ratio
4.77
Revenue / Employee
n/a
Employees
n/a
Market Cap
12.28M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Feb 28, 20262.77M688.14K33.00%
Feb 28, 20252.09M1.06M104.34%
Feb 29, 20241.02M302.13K42.06%
Feb 28, 2023718.30K-1.03M-59.00%
Feb 28, 20221.75M996.72K131.98%
Feb 28, 2021 Pro Pro Pro
Feb 29, 2020 Pro Pro Pro
Feb 28, 2019 Pro Pro Pro
Feb 28, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.